Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance

Figure 1

HE4 and CA125 levels in recurrent endometrial cancer. Box Plot of HE4 levels at three different time points demonstrating median and interquartile ranges with bars demonstrating 95% confidence intervals for 26 patients who developed recurrent endometrial cancer (A) and 72 patients who remained disease free (B). Box Plot of CA125 levels at three different time points demonstrating median and interquartile ranges with bars demonstrating 95% confidence intervals for 26 patients who developed recurrent endometrial cancer (C) and 72 patients who remained disease free (D).

Back to article page